Biogen Idec Inc. (BIIB) was a big mover last session, as its shares rose over 11% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the company, as the stock is now trading above the volatile price range of $299.29 to $331.15 in the past one-month timeframe.
In the last 30 days, the company witnessed one positive estimate revision and the Zacks Consensus Estimate also moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.
Biogen Idec currently has a Zacks Rank #1 (Strong Buy) while its Earnings ESP is 0.00%.
Better-ranked medical stocks include Curis, Inc. (CRIS), Enzo Biochem Inc. (ENZ) and The Medicines Company (MDCO). All three carry the same Zacks Rank as Biogen Idec.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment